Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Median Technologies    ALMDT   FR0011049824

MEDIAN TECHNOLOGIES (ALMDT)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

MEDIANTECHNOLOGIES : MEDIAN Technologies Names Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/04/2012 | 07:35am CEST

Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the relationship between MEDIAN and Quintiles

Regulatory News:

MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, announced today that it has named Ciaran Cooper as Head of Business Development, Clinical Trials Imaging, North America. Ciaran Cooper will be responsible for developing the company's US market in oncology clinical trials and will assist in managing the strategic relationship between MEDIAN Technologies and Quintiles.

Ciaran Cooper, an entrepreneur and early innovator in the clinical trials imaging services industry, brings over 20 years' experience in medical imaging with an emphasis in business development, strategic planning, and team management. Along with colleagues from the University of Chicago, Ciaran Cooper co-founded MIICRO, Inc. in 1995, the first imaging CRO specialized in early phase translational imaging with FDG PET. He was CEO of MIICRO until 2003. Since then, Ciaran Cooper has worked for several imaging services and technology companies as a senior manager in business development and thus brings with him a vast knowledge of various business models, therapeutic areas, and growth strategies.

"I'm very excited to join MEDIAN at this time in their development," said Ciaran Cooper. "MEDIAN's LMS solution provides a quantum leap forward in how medical imaging can be applied to oncology clinical trials. I look forward to carrying our message to market."

"We're thrilled to welcome Ciaran to our team," said Jerome Windsor, VP Business Development at MEDIAN Technologies. "Ciaran has a unique perspective on the industry and he brings an entrepreneurial spirit and enthusiasm that will fit well with our growing company."

About MEDIAN Technologies: MEDIAN Technologies provides advanced imaging solutions for diagnosing and monitoring cancer patients in clinical trials and in routine clinical practice. MEDIAN collaborates with institutes at the cutting edge of medical imaging, including the French National Institute for Computer Science and Control (INRIA), the University of Chicago, and the Swiss Federal Institute of Technology in Lausanne, Switzerland (EPFL). MEDIAN is present in the market through direct and indirect sales of its LMS solutions and through alliances with specialist cancer centers in Europe and the USA. MEDIAN has a strategic partnership with Quintiles, to offer integrated imaging services for clinical trials to customers worldwide.

Based in Sophia Antipolis, France, MEDIAN was founded in 2002 by Fredrik Brag (Current CEO), Gérard Milhiet, and Arnaud Butzbach. The company has a staff of 40, over half of whom work in R&D, and has a US-based subsidiary.

For more information on MEDIAN, please visit: www.mediantechnologies.com

MEDIAN Technologies
Fredrik Brag, CEO
+33 4 92 90 65 82
[email protected]
or
Press - ALIZE RP
Caroline Carmagnol
+ 33 6 64 18 99 59 // + 33 1 42 68 86 43
[email protected]
Anne-Sophie Cosquéric
+ 33 1 42 68 86 41
[email protected]


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIAN TECHNOLOGIES
05/31MEDIAN TECHNOLOGIES : to Attend the 2018 ASCO Annual Meeting, June 1-5, 2018, Mc..
BU
05/31MEDIAN TECHNOLOGIES : Monthly statement on outstanding equity shares and voting ..
CO
05/24MEDIAN TECHNOLOGIES : Appoints Dr. Yan Liu as Medical Director, Europe
BU
05/24MEDIAN TECHNOLOGIES : Nomination
CO
04/30MEDIAN TECHNOLOGIES : Monthly statement on outstanding equity shares and voting ..
CO
04/26MEDIAN TECHNOLOGIES : Launches ImageBank™
BU
04/12MEDIAN TECHNOLOGIES : Reports Full Year 2017 Financial Results
BU
04/12MEDIAN TECHNOLOGIES : Annual results
CO
03/31MEDIAN TECHNOLOGIES : Monthly statement on outstanding equity shares and voting ..
CO
03/12MEDIAN TECHNOLOGIES : and the Nice University Hospital (CHU De Nice) Announce Ag..
BU
More news
Chart MEDIAN TECHNOLOGIES
Duration : Period :
Median Technologies Technical Analysis Chart | ALMDT | FR0011049824 | 4-Traders
Technical analysis trends MEDIAN TECHNOLOGIES
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Managers
NameTitle
Fredrik Bjjorn Brag Chairman, CEO & Head-Investor Relations
Jeanne Hecht Director & Chief Operating Officer
Bernard Reymann Chief Financial Officer
Loan Hoang-Sayag Chief Medical Officer
Peter Bannister Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
MEDIAN TECHNOLOGIES-22.00%96
MICROSOFT CORPORATION17.91%769 319
RED HAT46.77%31 091
SPLUNK INC41.51%16 798
ATLASSIAN CORPORATION PLC45.25%15 473
CITRIX SYSTEMS22.14%14 493